|
Volumn 27, Issue 7, 2005, Pages 426-428
|
Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HYBRID PROTEIN;
ADENOVIRUS;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HEAD AND NECK TUMOR;
HUMAN;
INTRALESIONAL DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
SQUAMOUS CELL CARCINOMA;
TUMOR SUPPRESSOR GENE;
ADENOVIRIDAE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
FEMALE;
GENE THERAPY;
GENES, P53;
GENETIC VECTORS;
HEAD AND NECK NEOPLASMS;
HUMANS;
INJECTIONS, INTRALESIONAL;
MALE;
MIDDLE AGED;
RECOMBINANT FUSION PROTEINS;
|
EID: 34848829843
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (35)
|
References (0)
|